Advertisement

Topics

Merck Calls It Quits On Anacetrapib

16:51 EDT 11 Oct 2017 | SCRIP

Despite the success in the REVEAL outcomes trial for the cholesteryl ester transfer protein (CETP) inhibitor, Merck will not submit...

      

Related Stories

 

Original Article: Merck Calls It Quits On Anacetrapib

NEXT ARTICLE

More From BioPortfolio on "Merck Calls It Quits On Anacetrapib"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...